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Background and Aim. Lipedema is a common painful SAT disorder characterized by enlargement of fat primarily in the legs of
women. Case reports of lipedema tissue samples demonstrate ﬂuid and ﬁbrosis in the interstitial matrix, increased macrophages,
and adipocyte hypertrophy. -e aims of this project are to investigate blood vasculature, immune cells, and structure of lipedema
tissue in a cohort of women.Methods. Forty-nine participants, 19 controls and 30 with lipedema, were divided into groups based
on bodymass index (BMI): Non-Obese (BMI 20 to <30 kg/m2) andObese (BMI 30 to <40 kg/m2). Histological sections from thigh
skin and fat were stained with H&E. Adipocyte area and blood vessel size and number were quantiﬁed using ImageJ software.
Markers for macrophages (CD68), mast cells (CD117), Tcells (CD3), endothelial cells (CD31), blood (SMA), and lymphatic (D2-
40 and Lyve-1) vessels were investigated by IHC and IF. Results. Non-Obese Lipedema adipocyte area was larger than Non-Obese
Controls (p � 0.005) and similar to Obese Lipedema and Obese Controls. Macrophage numbers were signiﬁcantly increased in
Non-Obese (p< 0.005) and Obese (p< 0.05) Lipedema skin and fat compared to Control groups. No diﬀerences in T lymphocytes
or mast cells were observed when comparing Lipedema to Control in both groups. SMA staining revealed increased dermal vessels
in Non-Obese Lipedema patients (p< 0.001) compared to Non-Obese Controls. Lyve-1 and D2-40 staining showed a signiﬁcant
increase in lymphatic vessel area but not in number or perimeter in Obese Lipedema participants (p< 0.05) compared to Controls
(Obese and Non-Obese). Areas of angiogenesis were found in the fat in 30% of lipedema participants but not controls. Conclusion.
Hypertrophic adipocytes, increased numbers of macrophages and blood vessels, and dilation of capillaries in thigh tissue of non-
obese women with lipedema suggest inﬂammation, and angiogenesis occurs independent of obesity and demonstrates a role of
altered vasculature in the manifestation of the disease.
1. Introduction
Lipedema is a common painful subcutaneous adipose tissue
(SAT) disorder described in 1940 by Allen and Hines [1].
Lipedema develops during hormonal changes including
pregnancy, childbirth, or menopause and may aﬀect ap-
proximately 11% of adult women worldwide [2]. Lipedema
is characterized by a disproportion of nodular, painful fat on
the lower body compared to the trunk; arms are also aﬀected
in 80% of patients [2, 3]. Women with lipedema are often
misdiagnosed with obesity or lymphedema. Importantly,
lipedema fat is highly resistant to diet and exercise [4–7].
-ere are three stages of lipedema: Stage 1 with ﬂat skin
over pearl-sized nodules in a hypertrophic fat layer; Stage 2
with skin indentations over a hypertrophic fat structure of
pearl-to-apple-size masses; and Stage 3 with pearl-sized
nodules and much larger fat masses causing lobules of
skin and fat to form particularly on the hips, thighs, and
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around the knees. Lymphedema, causing ﬂuid accumulation
in the limbs, may develop during any stage of lipedema
especially Stage 3 [2], referred to as lipolymphedema. Flow
in lymphatics in early stages of lipedema appears normal but
can become impeded in later stages accompanied by
microaneurysms and leak [7]. Furthermore, hypermobility,
venous disease, and obstructive sleep apnea are common in
women with lipedema, predominantly Stage 3 [2].
Histology of lipedema fat found in case reports dem-
onstrates hypertrophy and hyperplasia of adipocytes as-
sociated with replicating mesenchymal stem cells [8],
dilation of subdermal blood capillaries and perivascular
cells, ﬁbrosis of arterioles, and ﬁbrosis and dilation of
venules [9]. One report found increased numbers of blood
vessels especially capillaries and prominent venules [10].
Large clusters of macrophages [11] and oil cysts [10, 12]
have been reported.
-is work investigates the histology of thigh skin and fat
in women living with lipedema focusing on adipocyte size,
immune cells inﬁltrating the tissue, and blood and lymphatic
vessel size and number to gain insight into whether these
tissue components might provide some insight into the
pathophysiology of lipedema.
2. Materials and Methods
2.1. Participants. All participants provided written informed
consent prior to participation. Protocols were reviewed and
approved by the Human Research and Protection Program
at the University of Arizona (Table 1). Participants were
determined to have lipedema based on the criteria of Wold
et al. [13]. Women with lipedema had symmetric hyper-
trophy of leg fat with pearl-sized nodules, tenderness to
palpation, reported swelling and diﬃculty, and a dispro-
portion of fat on the legs compared to the trunk that was
diﬃcult to lose by diet or exercise.
2.2. Biopsy. Punch biopsies (5mm) were obtained from the
anterolateral thigh. After injection of 1.5ml (3.78 μ mole)
lidocaine 2% (sc-362977Rx, TX, USA), skin and fat were
removed and placed immediately into 10% formalin con-
tainers. -e wound was closed with 2–4 absorbable sutures
and covered in gauze and Tegaderm.
2.3. Slide Preparation. Formalin-ﬁxed tissue samples were
embedded in paraﬃn, and 5 μm sections were cut for H&E
staining, immunohistochemistry, and immunoﬂuorescence.
2.3.1. Adipocyte Size. All images were captured at 20x
magniﬁcation (objective lens) using an EVOS XL Cell Im-
aging System. A total of 150 adipocytes were measured in 5
diﬀerent ﬁelds per participant from H&E-stained histo-
logical sections. Analysis of adipocyte area was performed
with ImageJ software (http://rsbweb.nih.gov/ij/). Adipocyte
size greater than 100 μm in diameter is considered hyper-
trophic [14].
2.3.2. Immunohistochemistry. Tissue sections (skin and fat)
were stained with markers for macrophages (CD68, DAKO/
Agilent M0814, CA, USA), mast cells (CD117, BioCare
CM5296C, CA, USA), T lymphocytes (CD3, Leica NCL-L-
CD3-565, IL, USA), endothelial cells (CD31, DAKO/Agilent
M0823, CA, USA), blood vessels (SMA, -ermo MS-113-P,
MA, USA), and lymphatic vessels (D2-40, Biolegend SIG-
3730, CA, USA), counterstained with hematoxylin; positive
and negative controls were included (San Diego Pathologists
Medical Group, CA, USA). Angiogenesis was assessed by
Masson’s trichrome stain (Sigma kit HT102A-1KT, MO,
USA). All sections were coded and scored in a blinded
manner by two independent investigators. -e quantiﬁca-
tion of CD3, CD68, and CD117 positive cells was expressed
as the average of total number of cells counted in 10 ﬁelds at
20x magniﬁcation (ﬁve ﬁelds in skin and ﬁve in fat).
2.3.3. Immunoﬂuorescence. Tissue sections were deparaﬃ-
nized using standard xylene through ethanol (100%, 95%,
90%, 80%, and 70%) steps (15min each). After de-
paraﬃnization, the slides were placed into 0.01% sodium
borohydride for 30min for mild antigen retrieval. -e slides
were then blocked in 10% normal goat serum for 2 hours at
room temperature and then incubated in primary antibody
(Lyve-1, abcam, ab14917) 1 : 200 in 1% normal goat serum/
0.01% triton X-100 in PBS overnight. -e slides were then
washed in PBS and incubated with secondary antibody (goat
anti-rabbit AlexaFluor 488) 1 :1000 for 2 hours at room
temperature and then washed 3 times in PBS.-e slides were
mounted using Prolong Gold Antifade reagent with DAPI.
2.4. Blood Vessels. Blood vessels were counted at 20X
magniﬁcation in 10 ﬁelds in SMA-stained sections. Arte-
rioles, venules, and capillaries were counted in the dermis of
skin including the epidermal/subpapillary (upper) and
papillary (lower papillary dermis above or at the junction of
the reticular dermis); capillaries were counted, and the
Table 1: Characteristics of control and lipedema subjects.
Characteristics Control Lipedema
Non-Obese
N 10 16
Sex Female Female
Age 40.6± 4.2 43.3± 2.5
BMI 23.5± 0.7 25.2± 0.5
Stage 1 — 8
Stage 2 — 7
Stage 3 — 1
Diabetes 0 0
Obese
N 9 15
Sex Female Female
Age 43.3± 5.2 46.1± 2.4
BMI 34.1± 1.4 34.1± 0.8
Stage 1 — 1
Stage 2 — 12
Stage 3 — 2
Diabetes 0 0
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diameter was measured in the hypodermal fat using ImageJ
software.
2.5. Lymphatic Vessels. Examination of lymphatic vessels
was limited to the dermal skin (papillary and reticular layers)
as there were few lymphatic vessels within the hypodermal
fat. Dermal tissue sections stained with Lyve-1 or D2-40
were imaged at 20X magniﬁcation (3 random ﬁelds of view
per sample); vessel structures identiﬁed by endothelial
staining were measured (maximum 10 and minimum 6
vessels per tissue).-e luminal perimeter of the vessels in the
tissue (determined by endothelial staining) was traced in
ImageJ, and the perimeter, area, and aspect ratio were
measured and averaged for each sample (Figure S1, Sup-
plementary Materials for Lymphatic methodology). -ere
were no diﬀerences within groups for vessel measurements
from Lyve-1 and D2-40 stained tissues.
2.6. Statistical Analyses. GraphPad PRISM 5 (Version 5.03)
was used for all statistical analyses. Results are displayed as
minimum/maximum box-whisker plots where the median
value is indicated by the solid horizontal line within each
box. -e Mann–Whitney test was used to determine the
diﬀerences between the two groups of participants. One-way
ANOVA followed by Tukey’s post hoc test was used to
analyze the diﬀerences between the four groups. Asterisks
(∗) indicate statistical signiﬁcance: ∗p< 0.5; ∗∗p< 0.01;∗∗∗p< 0.001.
3. Results
3.1.Demographics. Forty-nine participants, 19 non-lipedema
controls and 30 with lipedema, were divided into two groups
based on BMI (Table 1): Non-Obese (BMI 20 to <30 kg/m2)
and Obese (BMI 30 to <40 kg/m2). -ree lipedema partici-
pants had prediabetes and none had diabetes; none of the
controls had prediabetes or diabetes.
3.2. AdipocyteArea. Heterogeneity in adipocyte cell size was
observed in fat from all participants, ranging from 40 to
200 μm in diameter (Figure 1(a); Figure S2, Supplementary
Materials). A signiﬁcant increase was found in the adipocyte
area of Non-Obese Lipedema participants (p � 0.005)
compared to Non-Obese Controls; there was no diﬀerence
between the Obese groups (Figure 1(b)). -e average adi-
pocyte area was larger in Obese Controls compared to Non-
Obese Controls (Figure 1(b)).
3.3. Immune Cells. -e number of macrophages, but not
T-lymphocytes or mast cells, was signiﬁcantly higher in skin
and fat of Non-Obese and Obese Lipedema participants
compared to Controls in both groups (p< 0.05; Figures 2(b),
2(d), and 2(f)). Macrophages were detected throughout the
skin in lipedema participants (Figure 2(a)) and around
adipocytes in the hypodermal fat; in a few cases (12.5% in the
Non-Obese Lipedema group and 14% in the Obese Lipe-
dema group), macrophages encircled adipocytes forming
crown-like structures (CLS). No CLS were observed in
control groups. Mast cells and T lymphocytes were found
primarily around blood vessels in the papillary dermal layer
of the skin (Figures 2(c) and 2(e)) and around vessels in the
fat in all participants.
3.4. Blood Microvessel Evaluation in the Papillary Dermis.
SMA staining revealed dermal blood vessels extending to the
epidermis in lipedema participants and controls
(Figures 3(a) and 3(b)). Quantiﬁcation of these blood vessels
showed a signiﬁcant increase in their number in the lower
papillary dermal layer in the skin in Non-Obese Lipedema
participants compared to controls (p< 0.001; Figure 3(C)).
-e increase in blood vessel numbers positively correlated
with macrophage numbers in the Non-Obese Lipedema
group (Figures S3, Supplementary Materials, p � 0.05,
r2 � 0.45) but not in the Obese group.
3.5. Blood Microvessel Evaluation in Fat. -e ratio of the
number of capillaries to adipocytes in lipedema participants
was similar to controls in both groups (Figure 4(a)). Cap-
illary diameter was signiﬁcantly larger in the fat of Non-
Obese Lipedema participants but not in the Obese group,
compared to controls (p< 0.05; Figure 4(b)).
-irty percent of Non-Obese Lipedema participants
developed a striking hypervascularity in the fat conﬁrmed by
CD31 and SMA positive stain (Figures 5(b) and 5(c)).
Macrophages, mast cells, and ﬁbrosis were detected in
hypervascular areas mainly around blood vessels
(Figures 5(d)–5(f)).
3.6. Lymphatic Microvessel Evaluation in the Dermal Skin.
-ere was no signiﬁcant diﬀerence in the number of lym-
phatic vessels between controls and lipedema in both groups.
Examination of the morphological aspects of the vessels
revealed a signiﬁcant increase in the lymphatic vessel area in
Obese Lipedema participants compared to Non-Obese
Lipedema participants and Obese Controls (p< 0.01;
Figure 6(a)). No signiﬁcant diﬀerence was found for the
lymphatic vessel perimeter within Obese and Non-Obese
groups (Control and Lipedema). -e aspect ratio of vessels
from Obese participants tended to be higher than Non-
Obese participants, but there was no signiﬁcant diﬀerence
between Control and Lipedema within the groups. -e area/
perimeter ratio (a measure of vessel stretch) was signiﬁcantly
higher in Obese Lipedema participants than either Control
Obese or Non-Obese Lipedema participants (Figure 6(b),
p< 0.01).
4. Discussion
Lipedema tissue case reports suggest lipedema fat has hy-
pertrophic adipocytes [15]. In obesity, hypertrophic adi-
pocytes are markers of inﬂammation, ﬁbrosis, angiogenesis,
and metabolically changed fat [14, 16]. -is study was
conducted to contrast lipedema fat to non-lipedema fat
(controls) in groups of women, Non-Obese and Obese, to
Journal of Obesity 3
conrm or not previous case report data. e cellular ar-
chitecture of adipose tissue, types and numbers of immune
cells, and blood and lymphatic vessels, were investigated in
an area where lipedema fat is prominent, the thigh.
Histological examination of fat demonstrated a het-
erogeneity in cell size in Non-Obese and Obese fat from
lipedema participants as conrmed previously [15]; how-
ever, it was also present in controls; therefore, heterogeneity
of adipocyte size is not a good marker of lipedema fat. e
number of hypertrophic fat cells was greater in Obese
compared to Non-Obese Controls as expected. However, in
lipedema, the number of hypertrophic fat cells in the Non-
Obese group was similar to that in Obese Lipedema and
Control groups, and both were comparable in number the
Obese Control group. erefore, adipocyte hypertrophy in
lipedema participants occurs independent of obesity by the
usual measure of BMI.
e increase in adipocyte size in Non-Obese Lipedema
participants occurred in association with increased mac-
rophages in skin and fat as can be found in presumed non-
lipedema obesity [17, 18]. ese data suggest that lipedema
fat in the gynoid distribution, even in non-obese women, has
similar histological features of typical obesity. Finding CLS
in lipedema fat has been reported previously [15, 19]. CLS
are also found in adipose tissue from obese individuals but is
unusual in the fat of non-obese individuals, suggesting that
in lipedema fat, whether obese or non-obese, markers of a
metabolically poor tissue are present, including dead adi-
pocytes. e presence of CLS is also not consistent with the
low rate of diabetes found in this population [20]. e lo-
cation of the lipedema fat in the gynoid area may reduce the
overall metabolic eect on the body, in part by lower
postprandial triglyceride levels [21].
Angiogenesis, dened as the sprouting of new blood
vessels from preexisting functional vessels and capillaries, is
a multistep process involving vasodilation, matrix degra-
dation, and activation and migration of endothelial cells to
form new lumens [22, 23].e papillary dermal skin in Non-
Obese Lipedema participants in the lower layer had an
increase in blood vessel numbers compared to controls, and
Obese Lipedema participants had higher numbers of vessels
in the upper layer of the papillary dermis suggesting in-
creased angiogenesis in lipedema skin. e extension of the
dermal vessels to the epidermal layer is a very interesting
nding in lipedema as it has only been reported in psor-
iaform dermatoses [24, 25], inammatory conditions of the
skin.
While overall blood vessel count was not increased in
lipedema fat by the capillary/adipocyte ratio, there was a
signicant dilation of capillaries in Non-Obese Lipedema
participants as compared to Non-Obese Controls. Adding to
that, angiogenesis was observed in the fat layer of 30% of
Non-Obese Lipedema participants as demonstrated by
abundant dilated capillaries surrounding adipocytes along
with brosis and increased number of inltrating immune
cells.
is increase in blood vessel number and size in lipe-
dema associated with an increase in macrophage numbers
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Figure 1: Adipocyte area measured in Non-Obese and Obese participants with and without lipedema (controls). (a) Representative H&E
images showing heterogeneity and hypertrophy in cell size in adipocytes in leg fat of Non-Obese participants (scale bar 200 µm). (b) Box
and whisker plot representing the average adipocyte area in Non-Obese (Control n  10; Lipedema n  10) and Obese groups (Control
n  9; Lipedema n  11) (∗p< 0.05; ∗∗p< 0.01).
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highlights an essential role of macrophages in inammation
and angiogenesis [16, 26, 27]. Increased blood vessels in the
skin may therefore be an extension of underlying angio-
genesis in fat and may be a marker of angiogenesis in
lipedema.
Vascular endothelial growth factor (VEGF), a marker of
angiogenesis, was previously reported to have elevated levels
in the blood of ten women with lipedema compared to
controls [28], consistent with these data. It is unclear why the
robust angiogenesis occurred in the fat of some women with
lipedema and not others but may relate to hypoxia in the
tissue as suggested by Fife et al. [29]. e hypoxia may exist
due to enlarged adipocyte cell size or excess uid in tissue
from dysfunctional microvasculature or venous insu¢ciency,
both which need to be studied further in lipedema.
Changes in lymphatic vessels in skin from lipedema
participants were subtler than in the blood vasculature and
did not match the increased numbers of blood vessels found
in the skin and fat. e increase in the size (area) and area/
perimeter ratio of the lymphatic vessels in Obese Lipedema
tissues ts well with other data showing that, even in
clinically pure lipedema (uncomplicated by lymphedema),
there is an expansion of the vessels but no signicant
changes in transport [30]. is may be an early compen-
satory event to increased lymph generation or downstream
alterations in pressure in Obese Lipedema patients that is
absent in Non-Obese Lipedema participants. e fact that
most changes found herein in lymphatic vessel morphology
were only in Obese Lipedema participants suggests that
these individuals may have a greater risk of progressing to
lipolymphedema than non-obese participants, consistent
with clinical data [21, 31, 32].
Impaired dilation of capillaries is found in obesity [33],
much dierent from the dense clusters of dilated capillaries
found here in lipedema fat tissue. ese capillary clusters
appear similar to angiolipomas [8]. e increase in dilated
capillaries and in lymphatic vessels in the skin (in Obese
Lipedema participants) suggests an underlying cause for the
occurrence of lipedema tissue, specically alterations in cap-
illary structure resulting in dilation and leakage of excess uid
that is not readily picked up by lymphatic vessels.e probable
reason lymphatic size change is seen in Obese Lipedema and
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Figure 2: Immunohistochemistry of (a) CD68-labeled macrophages, (c) CD3-labeled T-lymphocytes, and (e) CD117-labeled mast cells in
leg fat of lipedema participants (arrows). Images captured with 20x objective lens. Box and whisker plots of (b) CD68, (d) CD3, and (f)
CD117 cell counts in skin and fat of control and lipedema participants. Non-Obese group (Control n  10; Lipedema n  10); Obese group
(Control n  7; Lipedema n  12) (∗∗p< 0.01).
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Figure 5: Angiogenesis in Non-Obese Lipedema leg fat. (a) H&E stain. Arrows indicate blood vessel lumens around adipocytes. (b, c)
Immunohistochemistry of CD31 and SMA conrms the blood vessel origin of the tissue structures. (d) Trichrome stain demonstrating
brosis in the areas of increased blood vessels. (e, f ) Immunohistochemistry of CD68-labeled macrophages and CD117-labeled mast cells
(arrows). Images captured at 40x objective lens (scale bar: 100 μm).
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Figure 4: Quantication of capillaries in the leg fat of Non-Obese and Obese participants with and without lipedema (controls). Box and
whisker plots of the (a) number of capillaries per adipocyte and (b) capillary diameter measured in Obese and Non-Obese Lipedema
participants compared to Controls. Non-Obese groups (Control n  10; Lipedema n  13); Obese groups (Control n  8; Lipedema n  14).
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not in Non-Obese Lipedema is due to changes in peripheral
perfusion resistance. Unlike the blood vascular system in which
capillary size is dictated by a number of dierent factors
(metabolism and local tissue signals), lymphatic vascular size is
predominantly regulated by tissue uid ux. In Non-Obese
Lipedema patients, there is capillary dilation, which despite
increased perfusion would not necessarily indicate a patho-
logically increased pressure, and therefore, no signicant
changes in the ux of uid and solute from the capillary into
the interstitial space and subsequently into the lymphatic are
detected. e constricted capillaries (relative to Non-Obese
Lipedema) of the Obese Lipedema patients would lead to the
classically observed increased peripheral resistance in obesity,
which given an equal central pressure and reection coe¢cient
of the capillaries, leads to increased blood vascular leak and
increased lymph formation, and that is why lymphatic size
increase is likely seen in Obese Lipedema and not in Non-
Obese Lipedema [34, 35]. is excess uid in the interstitial
tissue may induce growth of lipedema fat [36] as well as
hypoxia resulting in adipocyte cell death and the recruitment of
macrophages. Fibrosis follows inammation resulting in fat
that is di¢cult to lose by extreme measures (overexercise,
caloric-restricting or ketosis-generating diets, fasting, and
bariatric surgeries) [37, 38]. ese microvessel changes are
especially intriguing considering that hypermobile joints have
been found in a high percentage of women with lipedema,
suggesting a connective tissue disorder [20]. e connective
tissue alteration may promote changes in capillary structure
signaling angiogenesis that is not mirrored by lymphangio-
genesis, resulting in overload of the lymphatic system and uid
collection in the tissue, the denition of lipedema. Blood vessels
are highly innervated. e dilated capillaries may alter sensory
nerve function especially if accompanied by endothelial
damage, and an inammatory uid-overloaded interstitial
matrix within which nerves reside, might explain the pain
experienced by lipedema patients; women with lipedema, es-
pecially those with Stage 3 or any lipolymphedema should be
examined for neuropathy [39]. Preventing progression of the
disease should include modalities that improve uid ow
through the tissue, protect the integrity of blood vessel
structure, and reduce metabolic dysfunction of fat tissue.
5. Conclusion
Lipedema fat tissue even in non-obese women has classic
features of obesity including hypertrophic fat cells, CLS, and
increased macrophages. Dilated capillaries and angiogenesis
in the lipedema tissue in the absence of concomitant lym-
phangiogenesis suggest an inherent structural defect in the
capillaries allowing for increased ow of blood plasma into
fat tissues and an inability to remove it. e excess uid in
the tissue may stimulate fat to grow, and the inammation
generated stimulates brosis and di¢culty in weight loss.
Inammation and an interstitial uid stagnation may acti-
vate nerve bers resulting in the painful lipedema fat tissue.
Strategies are needed to improve all aspects of tissue
structure and ow.
Data Availability
e data used to support the ndings of this study are in-
cluded within the article and in the supplementary in-
formation le.
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Figure 6: Measurement of the lymphatic vessel area and perimeter in the dermal skin of Non-Obese and Obese participants with and
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cation of lymphatic vessel area and area/perimeter ratio
measurements. Non-Obese groups (Control n  7; Lipedema n  13); Obese groups (Control n  6; Lipedema n  14) (∗p< 0.05;∗∗p< 0.01).
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